Herb Blank 2022 provided a litmus test for ETFs designed to shield Investors from the full impact of a major stock market decline. The bad news is that half of them failed. The good news is that three of them actually did perform in line with their objectives. These are the results of a recent study that I co-authored … Read more
GARP is an acronym used in the investment industry to connote “growth at reasonable prices.” Last week, we discussed the market size and style trends year-to-date and what our models expect to see for the year ahead. The bottom line is that both our predictive and valuation models thought the mega-cap-weighted ETFs, such as QQQ, … Read more
In January, we published “Rotating Regimes – What to Plan For in 2023.” At that time, we recounted that the 2022 US Stock Market was a conflagration that wiped out almost everything in its path with the exception of a few industries and ETFs. At that time, we reported that two Benchmark ETFs we track, … Read more
Those of you who follow ValuEngine’s weekly lists of top-rated, (5 rated on scale of 1 to 5), Strong Buy stocks may have noticed that most of these stocks tend to be in the lower half of the market cap spectrum. This is a function of the fact that our scores are tied to our … Read more
Watching tech stocks lead the market resurgence in the first six weeks of Q1 2023, I was hit with a flash of déjà vu. Just six months ago, the market slaughter of the first six months of 2022 was led by a strong upsurge in the first six weeks of 2022 by beaten-up growth stocks. … Read more
Artificial intelligence (AI), the concept that a machine created brain could outperform the human brain, has fascinated and terrified humans since the days of Jules Verne. Real life examples such as Deep Blue defeating Chess Grandmaster Gary Kasparov and IBM Watson defeating Ken Jennings at Jeopardy intrigues us even more. Machine learning techniques, expert algorithms … Read more
Looking at this week’s list of stocks rated 5 (Strong Buy) from ValuEngine for year-ahead performance, I note that there are a number of relatively well-known large cap and midcap stocks that meet my minimum criteria as appropriate for conservative institutional-quality portfolios. As we will see, all five are in popular large cap and midcap … Read more
In general, the 2022 US Stock Market was a conflagration that wiped out almost everything in its path with the exception of a few industries and ETFs. The ETF reports on ValuEngine for ETFs that follow market benchmarks provide a side benefit in writing market analyses. They are a window to implicit forecasts for 3-, … Read more
I have spent 40 years helping to develop, research and market quantitative investment products with new twists. The advent of alternative data including the use of web-gathered information introduced new products in that regard. This has led to published papers in refereed journals such as “Using Alternative Research Data in Real World Portfolios” using data … Read more
I feel deluged lately by webinars and events touting investments in gold and precious metals. One theory pushed to support investment in these industry groups is that 1974 is here again. They claim it is inevitable that the market will tank further as the economy plunges into stagflation, a deeper recession accompanied by huge inflation … Read more